close

Products

1 141 142 143
Number of results: 2848
Date Compound Product name Company Disease Action mechanism Type of Information
0000-00-00
0000-00-00 Compound: bestttt vkh vki Action_mechanism: Company acquisition
0000-00-00 Compound: bestttt Laboratory Indication Action_mechanism:
0000-00-00 knjnlnlnln Product name:lknk nl nl lnl Licensing agreement
0000-00-00 test Establishment of a new subsidiary in the EU
0000-00-00 erenumab Aimovig® Amgen (USA - CA) migraine monoclonal antibody. AMG 334 is a fully human monoclonal antibody under investigation for the prevention of migraine. AMG 334 inhibits… Acceptation for review of a NDA
0000-00-00 assay service for understanding the impact of point mutations on protein therapeutic activity MutaMap™ ProImmune (UK) MutaMap is an in vitro assay system that explores the effect of deliberate point mutations on protein activity by substituting… Product launch
0000-00-00 SHP654 (BAX 888) • gene therapy. SHP654 (BAX 888) is an investigational factor VIII (FVIII) gene therapy intended to treat hemophilia A using a… Granting of the orphan status in the US